Can Natural Compounds From Food Targeting Heme Catabolic Pathway Provide Therapeutic Benefits?

The breakdown of heme by heme oxygenase (HMOX) produces bilirubin (BR) and biliverdin (BV), which are considered important endogenous modulators of human health. Researchers have recently explored the efficacy of natural compounds that target the enzymes involved in BR and BV production, with promising implications for novel therapeutics.

One such study published in Biomolecules examines the potential of natural compounds to influence BR and its associated enzymes. For instance, treatment with silymarin, an extract from milk thistle seeds, and flavonolignans has been found to slightly elevate total serum bilirubin (TSB) concentrations. Additionally, flavonoids have shown promise in treating neurodegenerative diseases and are being explored as potential chemoadjuvants.

Promising effects have been observed with fisetin, a natural compound, in a model of amyotrophic lateral sclerosis. Luteolin, another compound, has been found to enhance HMOX1 expression and is being considered as a phototherapeutic agent for Parkinson's Disease (PD) due to its anti-inflammatory and antioxidant properties.

Curcumin, derived from Curcuma longa, is a significant polyphenolic compound that induces HMOX1. Numerous studies have investigated the potential of curcumin as a nutraceutical in preventing neurodegeneration and neurotoxicity.

Astragaloside IV (AST), an active ingredient found in Astragalus membranaceus var. mongholicus, has shown neuroprotective effects in rats with ischemic stroke. In Alzheimer's disease (AD) patients, oxidative stress can be reduced by consuming vitamins C and E for one month. Furthermore, emerging evidence suggests that vitamin D deficiency may impair brain processes, such as cognition, and increase the risk of AD.

Several other natural compounds, including green tea, madecassoside, S-Allyl Cysteine, 20C, and Achyranthes bidentata, have been found to affect BR and its metabolic enzymes. These compounds offer potential therapeutic benefits and are derived from various plant sources.

In addition to targeting BR and its enzymes, researchers have explored natural compounds that mimic the products of the heme catabolic pathway. Phycocyanin, phycocyanobilin (PCB), and tetrapyrroles from Spirulina platensis are examples of such compounds. Spirulina platensis is rich in carotenoids, proteins, beneficial fatty acids, vitamins, and minerals, and has demonstrated anti-atherosclerotic and anti-cancer properties.

Phycocyanin and PCB, due to their antioxidant properties, show promise as therapeutic options for preventing diabetic nephropathy. Studies on male albino rats treated with streptozotocin have highlighted the antidiabetic effects of PCB, phycocyanin, and S. platensis.

Traditional Chinese medicine has long used artificial bezoar, which contains at least 25% BR by weight, in the treatment of various human diseases. Neuroprotective effects have been observed with artificial bezoar, particularly in reducing ischemic damage to the brain when pre-treated with Chinese medicine formulations containing bovine gallstones.

Chlorophyll, found in green leafy vegetables, has been associated with protection against cancer and neurodegenerative diseases. Recent studies have documented the antioxidant and antiproliferative effects of different forms of chlorophyll, including pheophytin a, chlorophyll a/b, and chlorophyllin.

Targeting specific parts of the heme catabolic pathway, such as HMOX1 modulation, holds promise for increasing BR levels in tissues and potentially treating autoimmune and neurodegenerative diseases. Compounds like flavonoids, curcuminoids, caffeic acid, resveratrol, and genistein have shown potential in this regard. Furthermore, the gut microbiome's role in metabolizing BR and potential modulation of BR levels warrants further investigation.

In conclusion, natural compounds that target the heme catabolic pathway offer exciting prospects for therapeutic interventions. By modulating key enzymes and processes involved in BR production, these compounds have the potential to combat various diseases while minimizing dietary alterations. However, further research is necessary to identify key natural food products and compounds that can effectively and safely target this pathway.